Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
US Army
Fish and Richardson
Argus Health
Deloitte
Chubb
Baxter
Teva
US Department of Justice

Generated: October 17, 2017

DrugPatentWatch Database Preview

Estazolam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for estazolam and what is the scope of estazolam patent protection?

Estazolam
is the generic ingredient in two branded drugs marketed by Watson Labs, Mayne Pharma, Par Pharm, and Abbott, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for estazolam. Five suppliers are listed for this compound.

Summary for Generic Name: estazolam

US Patents:0
Tradenames:2
Applicants:4
NDAs:4
Drug Master File Entries: see list3
Suppliers / Packagers: see list5
Bulk Api Vendors: see list27
Clinical Trials: see list2
Patent Applications: see list3,830
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:estazolam at DailyMed

Pharmacology for Ingredient: estazolam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma
ESTAZOLAM
estazolam
TABLET;ORAL074921-001Jul 10, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
ESTAZOLAM
estazolam
TABLET;ORAL074818-002Aug 19, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Abbott
PROSOM
estazolam
TABLET;ORAL019080-001Dec 26, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
Par Pharm
ESTAZOLAM
estazolam
TABLET;ORAL074826-002Jul 3, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Abbott
PROSOM
estazolam
TABLET;ORAL019080-002Dec 26, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
Watson Labs
ESTAZOLAM
estazolam
TABLET;ORAL074818-001Aug 19, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
ESTAZOLAM
estazolam
TABLET;ORAL074826-001Jul 3, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma
ESTAZOLAM
estazolam
TABLET;ORAL074921-002Jul 10, 1997ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: estazolam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
PROSOM
estazolam
TABLET;ORAL019080-001Dec 26, 1990► Subscribe► Subscribe
Abbott
PROSOM
estazolam
TABLET;ORAL019080-002Dec 26, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Novartis
Medtronic
US Department of Justice
Harvard Business School
Cantor Fitzgerald
Express Scripts
Chinese Patent Office
Daiichi Sankyo
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot